In conclusion, we identified ACSL3 as an unfavorable prognostic marker in CCA patients, demonstrating a significant association between high ACSL3 expression, increased levels of MUFA-PLs, and ferroptosis resistance in CCA cell lines (Fig. 9). Here, ACSL3 is linked to cholangiocarcinoma.